Efficacy of hormonal manipulation in lymphangioleiomyomatosis a 20-year-experience in 36 patients

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 1, 2007, Pages 39-50

  Schiavina, Mario ^a   Contini, Paola ^a   Fabiani, Andrea ^a   Cinelli, Franca ^a   Di Scioscio, Valerio ^a   Zompatori, Maurizio ^b   Campidelli, Cristina ^c   Pileri, Stefano A ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Estrogens; Hormonal manipulation; Oophorectomy; Tuberous sclerosis

Indexed keywords

AROMATASE INHIBITOR; LETROZOLE; LEUPRORELIN; MEDROXYPROGESTERONE; TRIPTORELIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY PLETHYSMOGRAPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE COMPARISON; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; LYMPHANGIOLEIOMYOMATOSIS; PRIORITY JOURNAL; SURVIVAL;

ADULT; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HORMONES; HUMANS; LEUPROLIDE; LUTEOLYTIC AGENTS; LYMPHANGIOLEIOMYOMATOSIS; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; RESPIRATORY FUNCTION TESTS; TRIPTORELIN;

EID: 36549086028     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Chu SC, Horiba K, Usuki J, et al: Comprehensive evaluation of 35 patients with Lymphangioleiomyomatosis. Chest 1999; 115: 1041-52.
2. Johnson S: Lymphangioleiomyomatosis: clinical features, management and basic mechanism. Thorax 1999; 54: 254-64.
3. Sullivan EJ: Lymphangioleiomyomatosis. A review. Chest 1998; 114: 1689-703.
4. Schiavina M, Fabiani A, Coraia B, et al: Lymphangioleiomyomatosis: clinical corse. Monaldi Arch Chest Dis 1994; 49: 1, 6-14.
5. Capron F, Ameille J, Leclerc P, et al: Pulmonary lymphangioleiomyomatosis and Bourneville's tuberous sclerosis with pulmonary involvement: the same disease? Cancer 1983; 52: 851-5.
6. Hauck RW, Konig G, Permanetter W, Weiss M, Wockel W, Fruhmann G: Tuberous sclerosis with pulmonary involvement. Respiration 1990; 57: 289-92.
7. Roach ES, Gomez MR, Northrup H: Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13 (12): 624-8.
8. Roach ES, Sparagana SP: Diagnosis of tuberous sclerosis complex. J Child Neurol 2004; 19 (9): 643-9.
9. Eliasson AH, Phillips YY, Tenholder MF: Treatment of Lymphangioleiomyomatosis A meta-analysis. Chest 1989; 196: 1352-5.
10. Yockey CC, Riepe RE, Ryan K: Pulmonary Lymphangioleiomyomatosis complicated by pregnancy. Kans Med 1986; 87: 277-278, 293.
11. Shen A, Iseman MD, Waldron JA, King TE: Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 1987; 91: 782-5.
12. Carrington CB, Cugell DW, Gaensler EA, et al: Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 1977; 116: 977-95.
13. Berkman N, Bloom A, Cohen P, et al: Bilateral spontaneous pneumothorax as the presenting feature in Lymphangioleiomyomatosis. Respir Med 1995; 89: 381-3.
14. Johnson SR, Tattersfield AE: Lymphangioleiomyomatosis: a UK survey. Thorax 1996; 51: A66.
15. Silverstein EF, Ellis K, Wolff M, Jaretski AI: Pulmonary Lymphangioleiomyomatosis. AJR 1974; 120: 832-50.
16. Sabattini E, Bisgaard K, Ascani S, et al: Envision Plus: a new immunohistochemical method of choice for diagnostics and research. Critical comparison with the APAAP. ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998; 51: 506-11.
17. Pileri SA, Roncador G, Ceccarelli C, et al: Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 1997; 183: 116-23.
18. Taveira-DaSilva AM, Hedin CM, Chen CC, Moss J: Bone mineral density studies in 104 patients with Lymphangioleiomyomatosis. Am J Respir Crit Care Med 2001; 163: A560.
19. Kristof AS, Moss J: Lymphangioleiomyomatosis. In: Interstizial Lung Disease. BC Decker Inc, Hamilton-London; 2003, 851-64.
20. Taylor JR, Ryu J, Colby TV, Raffin TA: Lymphangioleiomyomatosis. Clinical Course in 32 patients. N Engl J Med 1990; 323: 1254-60.
21. Kalassian KG, Doyle R, Kao P, Ruoss S, Raffin TA: Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997; 155: 1183-6.
22. Kalassian KG, Berry GJ, Raffin TA: Lymphangioleiomyomatosis. Clinical aspects. In: Moss J, editor. LAM and other diseases characterized by muscle proliferation. New York: Marcel DeKker, Inc: 1999, p. 9-31.
23. Kitaichi M, Nishimura K, Itoh H, Izumi T: Pulmonary Lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151: 527-33.
24. Corrin B, Liebow AA, Friedman PJ: Pulmonary Lymphangioleiomyomatosis. A review. Am J Patol 1975; 79: 347-82.
25. Cordier JF, et al: Perspectives on Lymphangioleiomyomatosis in France. In: Moss J, editor. LAM and other diseases characterized by muscle proliferation. New York: Marcel DeKker, Inc: 1999, p.9-31.
26. Baldi S, Papotti M, Valente ML, Rapellino M, Scappaticci E, Corrin B: Pulmonary Lymphangioleiomyomatosis in postmenopausal women: report of two cases and review of the literature. Eur Respir J 1994; 7: 1013-6.
27. Basset F, Soler P, Marsac J, Corrin B: Pulmonary Lymphangioleiomyomatosis. Three new cases studies with electron microscopy. Cancer 1976; 38: 2357-66.
28. Berstein SM, Newell JD Jr, Adamczyk D, Mortenson RL, King TE Jr, Lynch DA: How common are renal angiomyolipomas in patients with pulmonary Lymphangioleiomyomatosis? Am J Respir Crit Care Med 1995; 152: 2138-43.
29. Maziak DE, Kesten S, Rappaport DC, Maurer J: Extrathoracic angiomyolipomas in Lymphangioleiomyomatosis. Eur Respir J 1996; 9: 402-5.
30. Pileri SA, Cavazza A, Schiavina M, et al: Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change. Histopathology 2004; 44 (2): 156-63.
31. Urban T, Kutten F, Gompel A, Marsac J, Lacronique J: Pulmonary Lymphangioleiomyomatosis: follow-up and long term outcome with antiestrogen therapy: a report of eight cases. Chest 1992; 102: 472-6.
32. Kitzsteiner KA, Mallen RG: Pulmonary Lymphangioleiomyomatosis: treatment with castration. Cancer 1980; 46: 2248-9.
33. Banner AS, Carrington CB, Emory WB, et al: Efficacy of oophorectomy in Lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981; 305: 204-9.
34. Logan RF, Fawcett IW: Oophorectomy for pulmonary Lymphangioleiomyomatosis: a case report. Br J Dis Chest 1985; 79: 98-100.
35. Sieker OH, McCarty KS: Lymphangiomyomatosis: a respiratory illness with an endocrinologic therapy. Trans Am Clin Climatol Assoc 1987; 99: 57-67.
36. Zanella A, Toppan P, Nitti D, Lise M: Pulmonary Lymphangioleiomyomatosis: a case report in postmenopausal women treated with pleurodesis and progesterone (medroxyprogesterone acetate). Tumori 1996; 82: 96-8.
37. McCarty KS, Mossler JA, McClelland R, Seiker HO: Pulmonary Lymphangioleiomyomatosis responsive to progesterone. New Engl J Med 1981; 303: 1461-5.
38. Tomasian A, Greenberg MS, Rumerman H: Tamoxifen for Lymphangioleiomyomatosis. N Engl J Med 1982; 306: 745-6.
39. Clemm C, Jehn U, Wolf-Hornung B, Siemon G, Walter G: Lymphangioleiomyomatosis: a report of three cases treated with tamoxifen. Klin Wochenschr 1987; 65: 391-3.
40. De la Fuente J, Paramo C, Roman F, Perez R, Masa C, De Letona JM: Lymphangioleiomyomatosis: uncessfull treatment with luteinizing-hormon-releasing hormone analogues. Eur J Med 1993; 2: 377-8.
41. Eysvogel MMM, Page PS: Lymphangiomyomatosis. Chest 1990; 98: 1045-6.
42. Desurmont S, Bauters C, Copin MC, Dewailly D, Tonnel AB, Wallaert B: Treatment of Pulmonary Lymphangioleiomyomatosis using a GnRH agonist. Rev Mal Respir 1996; 13: 300-4.
43. Adamson D, Heinrichs WL, Raybin DM, Raffin TA: Successful treatment of Pulmonary Lymphangioleiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis 1985; 132: 916-21.
44. Brock ET, Votto JJ: Lymphangioleiomyomatosis: treatment with hormonal manipulation. N Y State J Med 1986; 86: 533-6.
45. El Allaf D, Borlee G, Hadjoudj H, Henrard L, Marcelle R, van Cauwenberge H: Pulmonary Lymphangioleiomyomatosis. Eur J Respir Dis 1984; 65: 147-52.
46. Yockey CC, Riepe RE, Ryan K: Pulmonary Lymphangioleiomyomatosis complicated by pregnancy. Kans Med 1986; 87: 277-278, 293.
47. Svedsen TL, Viskum K, Hansborg N, Thorpe SM, Nielsen NC: Pulmonary Lymphangioleiomyomatosis: a case of progesterone receptor positive Lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 1984; 78: 264-71.
48. Rossi GA, Balbi B, Oddera S, Lantero S, Ravazzoni C. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with Pulmonary Lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143: 174-176.
49. Klein M, Krieger O, Ruckser R, Rosen A, Waldner R, Preis P, Beck A. Treatment of Lymphangioleiomyomatosis by oophorectomy, interferon alpha 2b and tamoxifen - a case report. Arch Gynecol Obstet 1992; 252:99-102.
50. Luna CM, Gene R, Jolly EC, et al: Pulmonary Lymphangioleiomyomatosis associated with tuberous sclerosis: treatment with tamoxifen and tetracycline-pleurodesis. Chest 1985; 88: 473-5.
51. Boehler A, Speich R, Russi EW, Weder W: Lung transplantation for Lymphangioleiomyomatosis. N Engl J Med 1996; 335: 1275-80.
52. Trulock EP: Lung transplantation: special considerations and outcome in LAM. In: Moss J, editor. LAM and other diseases characterized by muscle proliferation. New York: Marcel DeKker, Inc: 1999, p. 9-31.
53. Bittmann I, Dose TB, Muller C, Dienemann H, Vogelmeier C, Lohrs U: Lymphangioleiomyomatosis recurrence after single lung transplantation. Hum Pathol 1997; 28: 1420-3.
54. O'Brien JD, Lium JH, Parosa JF, Deyoung BR, Wick MR, Trulock EP: Lymphangioleiomyomatosis recurrence in the allograft after single-lung transplantation. Am J Respir Crit Care Med 1995; 151: 2033-6.
55. Nine JS, Yousem SA, Paradis IL, Keenan R, Griffth BP: Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 1994; 13: 714-9.
56. Moss J, De Castro R, Patronas NJ, Taveira-Da Silva A: Meningiomas in Lymphangioleiomyomatosis. Jama 2001; 286: 1879-81.
57. Cottin V, Vukusic S, Jouanneau E, Lazor R, Cordier JF: Should patients with lymphangioleiomyomatosis undergo screening for meningioma? Eur Resp J 2004; 24: 888-9.
58. Pozzati E, Zucchelli M, Schiavina M, Contini P, Foschini MP: Rapid growth and regression of intracranial meningiomas in lymphangioleiomyomatosis: case report. Surg Neurol 2007; [Epub ahead of print].
59. Boehler A, Speich R, Russi EW, Weder W: International survey on lung transplantation in Lymphangioleiomyomatosis. In: Moss J, editor. LAM and other diseases characterized by muscle proliferation. New York: Marcel DeKker, Inc: 1999, p. 9-31.